View of Bispecific antibodies and chimeric antigen receptor (CAR) T-cell therapy for indolent lymphoma

Return to Article Details Bispecific antibodies and chimeric antigen receptor (CAR) T-cell therapy for indolent lymphoma Download Download PDF